PRISTIQ Drug Patent Profile
✉ Email this page to a colleague
When do Pristiq patents expire, and when can generic versions of Pristiq launch?
Pristiq is a drug marketed by Pf Prism Cv and is included in one NDA. There is one patent protecting this drug and two Paragraph IV challenges.
This drug has twenty-two patent family members in sixteen countries.
The generic ingredient in PRISTIQ is desvenlafaxine succinate. There are sixteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the desvenlafaxine succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pristiq
A generic version of PRISTIQ was approved as desvenlafaxine succinate by ALEMBIC on June 29th, 2015.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRISTIQ?
- What are the global sales for PRISTIQ?
- What is Average Wholesale Price for PRISTIQ?
Summary for PRISTIQ
International Patents: | 22 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Clinical Trials: | 23 |
Patent Applications: | 50 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PRISTIQ |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for PRISTIQ |
What excipients (inactive ingredients) are in PRISTIQ? | PRISTIQ excipients list |
DailyMed Link: | PRISTIQ at DailyMed |
![PRISTIQ drug patent expirations Drug patent expirations by year for PRISTIQ](/p/graph/s/t/PRISTIQ-patent-expirations.png)
![Drug Prices for PRISTIQ](/p/graph/drug-price/PRISTIQ.png)
![Drug Sales Revenue Trends for PRISTIQ](/p/graph/drug-sales-revenues/PRISTIQ.png)
Paragraph IV (Patent) Challenges for PRISTIQ
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
PRISTIQ | Extended-release Tablets | desvenlafaxine succinate | 25 mg | 021992 | 1 | 2015-05-08 |
PRISTIQ | Extended-release Tablets | desvenlafaxine succinate | 50 mg and 100 mg | 021992 | 12 | 2012-02-29 |
US Patents and Regulatory Information for PRISTIQ
PRISTIQ is protected by one US patents.
Patents protecting PRISTIQ
Derivatives of venlafaxine and methods of preparing and using the same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pf Prism Cv | PRISTIQ | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 021992-003 | Aug 20, 2014 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Pf Prism Cv | PRISTIQ | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 021992-001 | Feb 29, 2008 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Pf Prism Cv | PRISTIQ | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 021992-002 | Feb 29, 2008 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PRISTIQ
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pf Prism Cv | PRISTIQ | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 021992-003 | Aug 20, 2014 | ⤷ Sign Up | ⤷ Sign Up |
Pf Prism Cv | PRISTIQ | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 021992-001 | Feb 29, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Pf Prism Cv | PRISTIQ | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 021992-001 | Feb 29, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Pf Prism Cv | PRISTIQ | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 021992-002 | Feb 29, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Pf Prism Cv | PRISTIQ | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 021992-002 | Feb 29, 2008 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PRISTIQ
See the table below for patents covering PRISTIQ around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2305606 | ⤷ Sign Up | |
Israel | 200255 | METHOD OF PREPARING O-DESMETHYL-VENLAFAXINE | ⤷ Sign Up |
European Patent Office | 1864967 | ⤷ Sign Up | |
Hong Kong | 1057885 | ⤷ Sign Up | |
Cyprus | 1108202 | ⤷ Sign Up | |
Poland | 212943 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |